Jobs / United States / Glaxosmithkline LLC
Global Publication Director- Oncology
Glaxosmithkline LLC · 🇺🇸 4 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Position Summary The Global Publications Director leads the development of strategic publication plans aligned with Global Medical Plans, medical/scientific communication strategy, and objectives. The role ensures asset-specific plans connect with broader above-asset, portfolio, therapy area, disease area, and business publication strategies. The role leads matrix teams to develop long-term publication plans and align global priorities with regional and country needs. The Global Publications Director is responsible for timely execution of publication plans based on priorities, resources, GSK policies, good publication practices, and quality standards. The post-holder reviews priority publications, oversees publication tracking quality, and supports reporting and monitoring processes. The Global Publications Director may collaborate with a Publications Associate Director who oversees a specific asset or book of work. Key attributes include scientific integrity, publication and operational expertise, stakeholder management, strategic thinking, problem solving, agility, and the ability to lead change. The post-holder is expected to have a strong understanding of Good Publication Practice (GPP) and ICMJE guidance to support compliant, accurate, and timely publications. The role requires judgment in applying policy and practice recommendations to complex situations involving multiple internal and external stakeholders. The role champions innovation in scientific publication planning and execution, including the responsible evaluation, adoption, and integration of Artificial Intelligence (AI) and Generative AI (GenAI). The post-holder identifies opportunities to improve efficiency, quality, insight generation, and stakeholder experience through digital and AI-enabled solutions while maintaining governance, compliance, and scientific integrity. This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Lead cross-functional publication teams to develop strategic publication plans and execution tactics. • Partner with Medical to integrate publication plans into the medical strategic framework. • Ensure global, regional, and country alignment and input in collaboration with the Regional Publications team. • Maintain strong scientific knowledge of assigned assets, publication content, and the rationale for each planned publication. • Align above-asset publication strategy with individual asset publication plans. • Communicate publication plans clearly to varied audiences, including senior management. • Oversee publication plan execution within established best-practice and governance frameworks. • Manage external agencies supporting publication deliverables, as needed. • Maintain scientific integrity and ethics, and help ensure adherence to company policy or values. • Manage financial, contractual, and vendor-related aspects of assigned projects. • Build strong working relationships with internal stakeholders, including product teams and LOCs, and with external partners. • Serve as the publications expert and point of contact for internal and external stakeholders, including consultants, advisors, external experts, journals, and professional societies. • Act as spokesperson for publications within assigned disease areas or asset groups. • Manage complex stakeholder networks and tailor communication to functional and seniority-level needs. • Lead cross-functional initiatives that support overall team objectives. • Drive adoption of AI, GenAI, automation, and digital solutions to improve the efficiency, quality, and impact of publication planning, development, execution, and reporting. Partner across functions to evaluate, implement, and s